[Purpose]: The chick chorioallantoic membrane (CAM) assay can provide an alternative versatile, cost-effective, and ethically less controversial in vivo model for reliable screening of drugs. In the presented work, we demonstrate that CAM assay (in ovo and ex ovo) can be simply employed to delineate the effects of cisplatin (CDDP) and ellipticine (Elli) on neuroblastoma (Nbl) cells in terms of their growth and metastatic potential. [Methods]: The Nbl UKF-NB-4 cell line was established from recurrent bone marrow metastases of high-risk Nbl (stage IV, MYCN amplification, 7q21 gain). Ex ovo and in ovo CAM assays were optimized to evaluate the antimetastatic activity of CDDP and Elli. Immunohistochemistry, qRT-PCR, and DNA isolation were perfo...
International audienceFor therapeutic purposes, the development of new anti-cancer drugs requires th...
Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma accounting ...
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer with poor overa...
Purpose The chick chorioallantoic membrane (CAM) assay can provide an alternative versatile, cost-ef...
Background: Rapid development of novel treatment options demands valid preclinical screening models ...
The majority of ovarian cancer patients present with advanced disease and despite aggressive treatme...
The majority of ovarian cancer patients present with advanced disease and despite aggressive treatme...
International audienceBACKGROUND: The chick chorio-allantoic membrane (CAM) assay is a commonly used...
Survival rates of osteosarcoma patients could not be significantly improved by conventional chemothe...
Survival rates of osteosarcoma patients could not be significantly improved by conventional chemothe...
INTRODUCTION: The oral squamous cell carcinoma (OSCC) is a leading cause of death in human malignanc...
Ethical considerations, cost, and time constraints have highlighted the need to develop alternatives...
Abstract Background The chick chorio-allantoic membrane (CAM) assay is a commonly used method for st...
Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic head and neck cancer. However, me...
Introduction: Advancements in cancer management and treatment are associated with strong preclinical...
International audienceFor therapeutic purposes, the development of new anti-cancer drugs requires th...
Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma accounting ...
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer with poor overa...
Purpose The chick chorioallantoic membrane (CAM) assay can provide an alternative versatile, cost-ef...
Background: Rapid development of novel treatment options demands valid preclinical screening models ...
The majority of ovarian cancer patients present with advanced disease and despite aggressive treatme...
The majority of ovarian cancer patients present with advanced disease and despite aggressive treatme...
International audienceBACKGROUND: The chick chorio-allantoic membrane (CAM) assay is a commonly used...
Survival rates of osteosarcoma patients could not be significantly improved by conventional chemothe...
Survival rates of osteosarcoma patients could not be significantly improved by conventional chemothe...
INTRODUCTION: The oral squamous cell carcinoma (OSCC) is a leading cause of death in human malignanc...
Ethical considerations, cost, and time constraints have highlighted the need to develop alternatives...
Abstract Background The chick chorio-allantoic membrane (CAM) assay is a commonly used method for st...
Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic head and neck cancer. However, me...
Introduction: Advancements in cancer management and treatment are associated with strong preclinical...
International audienceFor therapeutic purposes, the development of new anti-cancer drugs requires th...
Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma accounting ...
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer with poor overa...